In Stent Restenosis After Drug-Eluting Stent Implantation in a Patient with Polycythemia Vera: A Case Report

I Gusti Ayu Ratna Dewi (Department of Emergency Medicine, Jantung Diagram Siloam Hospital, Depok, Indonesia)
Tristi Lukita Wening (Department of Emergency Medicine, Jantung Diagram Siloam Hospital, Depok, Indonesia)
Sidhi Laksono Purwowiyoto (Department of Cardiology and Vascular Medicine, Jantung Diagram Siloam Hospital, Depok, Indonesia Faculty of Medicine, Universitas Muhammadiyah Prof. Dr. Hamka, Tangerang, Indonesia)

Journal of Agromedicine and Medical Sciences
Vol 9 No 2 (2023)

Polycythemia vera happened in people around 40-60 years old and mostly men. The criteria are total red blood cells ≥36 mL/kg in males, thrombocytosis, leukocytosis, and JAK2 mutation. We present a case of a 63-year-old male with unknown history of polycythemia vera who came to our hospital with acute STEMI anterior, he previously had done a coronary angiogram at another hospital thirteen days ago and found out that his previous drug-eluting stent (DES) was total in-stent restenosis in proximal. To prevent recurrent ischemia events, we replaced Clopidogrel with Ticagrelor and continue Aspirin. Keywords: drug-eluting stent; in-stent restenosis; polycythemia vera